Review Article

Targeted Therapy in Ovarian Cancer

Table 3

Review of drugs in the epidermal growth factor receptor family that have been evaluated in ovarian cancer. RR: response rate, SD: stable disease, HTN: hypertension.

Agent(s)AuthorsRRSDToxicities

GefitinibSchilder et al.1/27Dermatologic, diarrhea
Gefitinib + tamoxifenWagner et al.0/5616/56Diarrhea, skin rash
ErlotinibGordon et al.2/34 partial15/34Rash, diarrhea
Erlotinib + bevacizumabNimeiri et al.1/13 complete7/13Anemia, nausea, vomiting, HTN, diarrhea, 2 fatal GI perforations
1/13 partial
TranstuzumabBookman et al.1/41 complete
2/41 partial
PertuzumabGordon et al.5/107 partial8/107Diarrhea